Asensus Surgical (formerly known as TransEnterix)

195 articles about Asensus Surgical (formerly known as TransEnterix)

• Asensus Surgical, Inc. Reports Operating and Financial Results for the First Quarter 2023

  5/11/2023

  Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced its operating and financial results for the first quarter 2023.

• Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2023

  4/27/2023

  Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, announced that it plans to release 2023 first quarter financial and operating results after the market closes on Thursday, May 11, 2023.

• Asensus Surgical Announces Fukuoka Tokushukai Hospital in Japan to Initiate Senhance Surgery Program

  4/25/2023

  Asensus Surgical, Inc. today announced that Fukuoka Tokushukai Hospital in Kasuga City, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System.

• Asensus Surgical to Participate in the H.C. Wainwright In-Person BioConnect Investor Conference

  4/19/2023

  Asensus Surgical, Inc. announced that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the H.C. Wainwright In-Person Bio-Connect Investor Conference.

• Asensus Surgical Receives FDA 510(k) Clearance For Pediatric Indication for Senhance Surgical System Senhance Offers the First and Only Digital Laparoscopic Surgery Solution for Pediatric Patients

  3/20/2023

  Asensus Surgical, Inc. today announced that it has received 510(k) clearance from the FDA for an expanded indication to treat pediatric patients with the Senhance® System.

• Asensus Surgical to Participate in the Oppenheimer 33rd Annual Healthcare Conference

  3/6/2023

  Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Anthony Fernando, President and Chief Executive Officer, and Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Oppenheimer 33rd Annual Healthcare Conference.

• Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2022

  3/2/2023

  Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™(PGS), today announced its operating and financial results for the fourth quarter and full year 2022.

• Asensus Surgical, Inc. to Release Fourth Quarter and Full Year 2022 Financial and Operating Results on March 2, 2023

  2/27/2023

  Asensus Surgical, Inc. announced today that it plans to release fourth quarter and full year 2022 financial and operating results after the market closes on Thursday, March 2, 2023.

• Asensus Surgical Provides Corporate Update

  2/21/2023

  Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, is providing this corporate update in conjunction with its previously announced Investor Day, which will be hosted , beginning at 11:30am EST.

• Asensus Surgical Announces Machine Learning and Cloud Infrastructure Collaboration with Google Cloud to Advance Performance-Guided Surgery

  2/14/2023

  Asensus Surgical, Inc. announced a multi-year collaboration with Google Cloud to integrate Google Cloud’s secure cloud data architecture and machine learning technologies to further expand the capabilities of the Asensus Surgical’s Performance-Guided Surgery™ framework enabled through the Intelligent Surgical Unit ™.

• Asensus Surgical to Ring New York Stock Exchange Opening Bell on February 21, 2023

  2/9/2023

  Asensus Surgical, Inc. announced that President and CEO Anthony Fernando will be joined by other leaders of the Company to ring the opening bell of the New York Stock Exchange on February 21, 2023.

• Asensus Surgical to Host Investor Day on February 21, 2023

  1/30/2023

  Asensus Surgical, Inc. today announced that the Company will host an Investor Day on Tuesday, February 21, 2023 in New York City.

• Asensus Surgical Receives CE Mark for Expanded Machine Vision Capabilities

  1/23/2023

  Asensus Surgical, Inc. today announced receipt of CE Mark for an expansion of machine vision capabilities on the previously cleared Intelligent Surgical Unit™ (ISU™).

• Asensus Surgical Provides Preliminary 2022 Year-End Corporate Update

  1/9/2023

  Asensus Surgical, Inc., a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, provided a preliminary 2022 year-end corporate update.

• Asensus Surgical, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

  1/5/2023

  Asensus Surgical, Inc. announced that the management team will participate and present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023 at 12:00 PM PST.

• Asensus Announces Kitakyushu General Hospital in Japan to Initiate Second Senhance System

  1/3/2023

  Asensus Surgical, Inc. announced that Kitakyushu General Hospital, a hospital in the Kyushu area of Japan, entered into an agreement to lease and utilize a second Senhance® Surgical System, at the end of December 2022.

• Asensus Announces Senhance Program Initiation at Kashiwa Kosei General Hospital of Japan

  12/29/2022

  Asensus Surgical, Inc. announced that Kashiwa Kosei General Hospital in Kashiwa, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System.

• Asensus Announces Senhance System Placement at GPR Klinikum Rüsselsheim of Germany10th hospital in Germany to initiate a Senhance System

  12/19/2022

  Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that GPR Gesundheits- und Pflegezentrum Klinikum of Rüsselsheim (“GPR”), Germany has entered into an agreement to lease and utilize a Senhance® Surgical System.

• Asensus Announces Additional Senhance Surgical System SaleOncology focused hospital to initiate Senhance System program

  12/8/2022

  Asensus Surgical, Inc. today announced that a Senhance ® Surgical System has been sold to the Company’s distribution partner in Germany focused on Eastern Europe and the Commonwealth of Independent States (CIS) region.

• Asensus Surgical to Participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference

  11/28/2022

  Asensus Surgical, Inc. (NYSE American: ASXC) announced today that Shameze Rampertab, Executive Vice President and Chief Financial Officer, will participate in the Cantor Medical & Aesthetic Dermatology, Ophthalmology & MedTech Conference in Miami, Florida.